Sahar Yazdanfard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sahar Yazdanfard has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bilqees Fatima
Health Building 2. Pharmaceutical Health Outcomes and Policy Department, College of Pharmacy, University of Houston, 4849 Calhoun Road, USA
2 shared publications - Fatin Atrooz
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA
1 shared publication - Marjan Zakeri
Columbia Data Analytics New York New York USA
1 shared publication - Samina Salim
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, United States
1 shared publication - Sarah Zeidat
Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX 77204, USA
1 shared publication - Sujit S. Sansgiry
Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX 77204, USA
1 shared publication
Latest Publications
- 21 April 2024
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 16 (7) , 102094
Integrated curriculum in the United States pharmacy programs
- 21 April 2024
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 16 (7) , 102094
Integrated curriculum in the United States pharmacy programs
- Open Access
Prevalence of Anxiety and Depression during the COVID-19 Pandemic in a Sample of Houston-Based Middle Eastern and North African Residents
The COVID-19 pandemic has contributed to anxiety and depression in many communities across the United States. Here, we have focused on a sample of Houston-based Middle Eastern and North African (MENA) residents and assessed the prevalence of anxiety and depression in this community. The 7-item Generalized Anxiety Disorder and the 9-item Patient Health Questionnaires were used to identify the prevalence and severity of anxiety and depression, respectively. A sociodemographic, general health, and COVID-19 survey was used for a multivariable logistic regression model to determine predictors of anxiety and depression. The outcome of interest was “minimal/mild” versus “moderate/severe” anxiety and depression. A total of 368 participants completed the survey, with 24.73% reporting “moderate/severe” anxiety and 31.79% reporting “moderate/severe” depression. Male participants were less likely (OR = 0.29, 95% CI = 0.12, 0.75) to have “moderate/severe” anxiety compared to females. Respondents with self-reported depression were more likely (OR = 3.41, 95% CI = 1.33, 8.83) to have “moderate/severe” depression. Participants who reported having “Excellent/Good knowledge” about the prevention of COVID-19 spread were less likely (OR = 0.37, 95% CI = 0.15, 0.93) to have “moderate/severe” depression, and less likely (OR = 0.22, 95% CI = 0.07, 0.64) to have “moderate/severe” anxiety, compared to those who had “average/poor/terrible” knowledge. Identified predictors may be critical for designing culturally sensitive interventions to improve the healthcare of MENA Americans.
Open AccessPrevalence of Anxiety and Depression during the COVID-19 Pandemic in a Sample of Houston-Based Middle Eastern and North African Residents
The COVID-19 pandemic has contributed to anxiety and depression in many communities across the United States. Here, we have focused on a sample of Houston-based Middle Eastern and North African (MENA) residents and assessed the prevalence of anxiety and depression in this community. The 7-item Generalized Anxiety Disorder and the 9-item Patient Health Questionnaires were used to identify the prevalence and severity of anxiety and depression, respectively. A sociodemographic, general health, and COVID-19 survey was used for a multivariable logistic regression model to determine predictors of anxiety and depression. The outcome of interest was “minimal/mild” versus “moderate/severe” anxiety and depression. A total of 368 participants completed the survey, with 24.73% reporting “moderate/severe” anxiety and 31.79% reporting “moderate/severe” depression. Male participants were less likely (OR = 0.29, 95% CI = 0.12, 0.75) to have “moderate/severe” anxiety compared to females. Respondents with self-reported depression were more likely (OR = 3.41, 95% CI = 1.33, 8.83) to have “moderate/severe” depression. Participants who reported having “Excellent/Good knowledge” about the prevention of COVID-19 spread were less likely (OR = 0.37, 95% CI = 0.15, 0.93) to have “moderate/severe” depression, and less likely (OR = 0.22, 95% CI = 0.07, 0.64) to have “moderate/severe” anxiety, compared to those who had “average/poor/terrible” knowledge. Identified predictors may be critical for designing culturally sensitive interventions to improve the healthcare of MENA Americans.